中国麻风皮肤病杂志 ›› 2025, Vol. 41 ›› Issue (5): 377-383.doi: 10.12144/zgmfskin202505377

• 综述 • 上一篇    下一篇

麻风反应治疗进展

夏凡茜,余美文   

  1. 北京协和医学院中国医学科学院皮肤病医院皮肤病研究所,江苏南京,210042
  • 出版日期:2025-05-15 发布日期:2025-05-15

Update on treatment of leprosy reaction

XIA Fanxi, YU Meiwen   

  1. Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing 210042, China
  • Online:2025-05-15 Published:2025-05-15

摘要: 麻风反应是麻风分枝杆菌所引发的免疫炎症反应,常导致患者的残疾和畸形。除传统的非甾体抗炎药、糖皮质激素、氯法齐明和沙利度胺以外,甲氨蝶呤、环磷酰胺、TNF-α抑制剂、阿普米司特等药物也用于麻风反应的治疗。本文对麻风反应治疗的药物种类、疗效、不良反应与耐药等方面进行综述。

关键词: 麻风反应, 治疗, 神经炎, 麻风性结节性红斑, 药物不良反应

Abstract: Leprosy reaction is an immunoinflammatory response triggered by Mycobacterium leprae, which often leads to disability and deformity in patients. Except for conventional nonsteroidal anti-inflammatory drugs(NSAIDs), glucocorticoid, clofazimine, and thalidomide, medications such as methotrexate, cyclophosphamide, tumor necrosis factor-α(TNF-α) inhibitors, and apremilast are also used in the treatment for leprosy reaction. This paper reviews the types of drugs, efficacy, adverse reactions and drug resistance in the treatment for leprosy reaction.

Key words: leprosy reaction, treatment, neuritis, erythema nodosum leprosum, adverse drug reactions